Carregant...

Lineage of origin in rhabdomyosarcoma informs pharmacological response

Lineage or cell of origin of cancers is often unknown and thus is not a consideration in therapeutic approaches. Alveolar rhabdomyosarcoma (aRMS) is an aggressive childhood cancer for which the cell of origin remains debated. We used conditional genetic mouse models of aRMS to activate the pathognom...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Abraham, Jinu, Nuñez-Álvarez, Yaiza, Hettmer, Simone, Carrió, Elvira, Chen, Hung-I Harry, Nishijo, Koichi, Huang, Elaine T., Prajapati, Suresh I., Walker, Robert L., Davis, Sean, Rebeles, Jennifer, Wiebush, Hunter, McCleish, Amanda T., Hampton, Sheila T., Bjornson, Christopher R.R., Brack, Andrew S., Wagers, Amy J., Rando, Thomas A., Capecchi, Mario R., Marini, Frank C., Ehler, Benjamin R., Zarzabal, Lee Ann, Goros, Martin W., Michalek, Joel E., Meltzer, Paul S., Langenau, David M., LeGallo, Robin D., Mansoor, Atiya, Chen, Yidong, Suelves, Mònica, Rubin, Brian P., Keller, Charles
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory Press 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102765/
https://ncbi.nlm.nih.gov/pubmed/25030697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/gad.238733.114
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!